Screening polypectomy rates below quality benchmarks: A prospective study

Table 1 Sex-specific polypectomy rates according to patient and endoscopist colonoscopy indications (n = 2134)

Colonoscopy indication1	Male		Female
	Screening PRs% (95%CI)	Non-screening PRs% (95%CI)	Screening PRs% (95%CI)	Non-screening PRs% (95%CI)
Patient	32.4 (23.8-41.8)	34.4 (27.0-41.9)	19.4 (13.1-25.4)	22.3 (16.3-28.6)
Endoscopista	30.2 (22.3-38.9)	37.3 (29.7-45.3)	16.6 (11.0-22.7)	26.3 (19.4-33.3)
Endoscopistb	31.4 (23.5-39.7)	36.1 (28.2-44.4)	17.6 (11.7-23.7)	25.2 (18.1-32.4)

¹Screening colonoscopy indications defined as follows: (1) Patient: colonoscopy performed in individuals without a history of either gastrointestinal conditions in the past 12 mo or large bowel symptoms in the past 6 mo; (2) Endoscopist^a: colonoscopy performed in asymptomatic individuals or those with a family history of colorectal cancer; and (3) Endocopist^b: colonoscopy performed in asymptomatic individuals or those with a family history of colorectal cancer; or reported as confirmatory colonoscopy (performed to follow-up on a positive screen). PRs: Polypectomy rates.